93 7702 (Glimepiride and rosiglitazone maleate 4 mg / 8 mg)
Pill imprint 93 7702 has been identified as Glimepiride and rosiglitazone maleate 4 mg / 8 mg.
Glimepiride/rosiglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glimepiride/rosiglitazone 4 mg / 8 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about glimepiride/rosiglitazone
- Side Effects
- During Pregnancy
- Drug Interactions
- Support Group
- 1 Review – Add your own review/rating
- Drug class: antidiabetic combinations
- Rosiglitazone and glimepiride
- Rosiglitazone and glimepiride (Advanced Reading)
Other brands: Avandaryl
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.